Immix Biopharma, Inc.
IMMX · NASDAQ
Bulios Fair Price
$7.64
37.1% downside
Trenutna cena
$12.14
Po podatkih Bulios Fair Price je delnica IMMX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Immix Biopharma, Inc. is a biotechnology company focused on researching and developing novel therapeutic treatments in the field of cancer immunotherapy. Their main focus is on harnessing the body's immune system to fight cancer through innovative treatment approaches, such as antigen-specific T-cell therapies. The company is developing and testing new therapeutic agents aimed at improving treatment efficacy and reducing side effects in patients with various types of cancer. Their research aims to identify and target specific molecules and processes that are crucial for immune response and regulatory mechanisms in combating cancerous diseases. Shares of Immix Biopharma, Inc. may be of interest to investors following innovations in cancer treatment and seeking investment opportunities in the biotechnology sector.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Ilya Rachman
Employees
21
Headquarters
Los Angeles
Prihajajoči dogodki
Earnings
Upcoming earnings report